Quantbot Technologies’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,995
Closed -$318K 2051
2021
Q1
$318K Buy
+3,995
New +$312K 0.03% 607
2020
Q3
Sell
-5,231
Closed -$231K 1767
2020
Q2
$231K Buy
5,231
+3,611
+223% +$135K 0.03% 391
2020
Q1
$58K Buy
+1,620
New +$92.1K 0.04% 409
2019
Q2
Sell
-14,900
Closed -$996K 1544
2019
Q1
$996K Buy
14,900
+12,100
+432% +$916K 0.09% 276
2018
Q4
$208K Sell
2,800
-11,495
-80% -$949K 0.02% 635
2018
Q3
$1.31M Buy
14,295
+10,324
+260% +$983K 0.09% 313
2018
Q2
$390K Buy
+3,971
New +$444K 0.03% 632
2017
Q4
Sell
-267
Closed -$25K 1584
2017
Q3
$25K Sell
267
-120
-31% -$9.47K ﹤0.01% 1038
2017
Q2
$30K Sell
387
-613
-61% -$46K ﹤0.01% 962
2017
Q1
$80K Sell
1,000
-1,133
-53% -$90K 0.01% 829
2016
Q4
$167K Buy
2,133
+743
+53% +$57.7K 0.02% 589
2016
Q3
$108K Buy
+1,390
New +$101K 0.01% 715

Quantbot Technologies's CMD Position: Q2 2021 in Review

Quantbot Technologies sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 3,995 shares — an estimated $318K sold.

Quantbot Technologies first reported a position in CMD in Q3 2016 and held it in 12 quarters. The position peaked at $1.31M in Q3 2018. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

  • Quantbot Technologies reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Quantbot Technologies sold 3,995 Cantel Medical Corporation shares in Q2 2021, an estimated $318K.
  • Quantbot Technologies first reported a position in Cantel Medical Corporation in Q3 2016 and held it in 12 quarters.
  • Quantbot Technologies's Cantel Medical Corporation position peaked at $1.31M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on Quantbot Technologies's 13F filing for Q2 2021, filed 12 Aug 2021.